Advertisement
The Body: The Complete HIV/AIDS Resource
Follow Us Follow Us on Facebook Follow Us on Twitter Download Our App
Professionals >> Visit The Body PROThe Body en Espanol
  
  • Email Email
  • Printable Single-Page Print-Friendly
  • Glossary Glossary
  • PDF PDF

HEPPigram: Management of Cervical Cytology

May 2001

A note from TheBody.com: Since this article was written, the HIV pandemic has changed, as has our understanding of HIV/AIDS and its treatment. As a result, parts of this article may be outdated. Please keep this in mind, and be sure to visit other parts of our site for more recent information!

Cervical Cytology Performed Q 6 Months


Infection with human papillomavirus (HPV) has been causally linked with the development of cervical cancer and over 90% of invasive cervical tumors harbor HPV DNA.(1, 2) Over 65 different HPV types have been identified and grouped into low-risk or high-risk categories on the basis of each type's association with a benign or malignant disease process.(3) The high-risk types 16 and 18 can be detected in roughly 70% of all invasive cervical tumors. PCR technology (polymerase chain reaction) has been the preferred methodology for virus identification and typing on isolated DNA, and will become an adjunct means of diagnosing HPV.

Persistent HPV infection is more prevalent among HIV-infected women, thus clinicians should be vigilant about Pap smears and close gynecologic follow-up.

* Cervical cytology is recommended every 6 months because the correctional population of women is at high risk for complications.

Advertisement

References

  1. Bosch, F. X., Manos, M. M., Munoz, N., Sherman, M., Jansen, A. M., et al. Prevalence of human papillomavirus in cervical cancer: a worldwide perspective. International biological study on cervical cancer (IBSCC) Study Group [see comments]. J Natl Cancer Inst, 87: 796-802, 1995.

  2. Liaw, K.L., Glass, A.G., Manos, M.M., Greer, C.E., Scott, D.R., Sherman, M., Bruk, et al. Detection of human papilllomavirus DNA in cytologiacally normal women and subsequent cervical squamous intraeptithelial lesions. J Natl Cancer Inst. 91 (11) 954-60 1999.

  3. Pecoraro, G., Morgan, D., and Defendi, V. Differential effects of human papillomavirus type 6, 16, and 18 DNAs on immortalization and transformation of human cervical epithelial cells. Proc. Natl. Acad. Sci. U.S.A., 86: 563-567, 1989.


Back to the HEPP News May 2001 contents page.

A note from TheBody.com: Since this article was written, the HIV pandemic has changed, as has our understanding of HIV/AIDS and its treatment. As a result, parts of this article may be outdated. Please keep this in mind, and be sure to visit other parts of our site for more recent information!



  
  • Email Email
  • Printable Single-Page Print-Friendly
  • Glossary Glossary
  • PDF PDF

This article was provided by Brown Medical School. It is a part of the publication HEPP News.
 
See Also
More on HPV and Cervical Cancer in HIV-Positive Women
Advertisement:
Find out how a Walgreens specially trained pharmacist can help you

Tools
 

Advertisement